Results 141 to 150 of about 54,406 (266)

The effects of perceived risk and responsibility on the acceptance of a Human Papillomavirus vaccine by college men [PDF]

, 2009
In the summer of 2006 the Food and Drug Administration approved a new vaccine to prevent four types of the Human Papillomavirus believed to cause the majority of genital warts and cervical cancer in women.
Mitiguy, Angela Marie
core   +1 more source

An Ad26‐MVA‐BN‐based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infections

Clinical &Translational Immunology, Volume 15, Issue 3, 2026.
Immunisation with adenovirus (Ad) vectors followed by Modified Vaccinia Virus Ankara—strain Bavarian Nordic (MVA‐BN) vectors expressing HPV16 and HPV18 engineered antigens induced antigen‐specific polyfunctional T cells in mice, rhesus macaques and persistent HPV16/HPV18 infected human females vaccines (n = 5). These data showed the promise of the Ad26‐
Selina Khan, Satish Boedhoe, Miranda Baert, Jan Serroyen, Thierry Verbinnen, Ariane Volkmann, Markus Kalla, Katrin Weidner, Mathieu Le Gars, Jerry Sadoff, Michal Sarnecki, Jort Vellinga, Jerome Custers, Gert Scheper, Hanneke Schuitemaker, Roland Zahn   +15 more
wiley   +1 more source

The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa, Agness Shimilimo, Olivier Uwishema, Helen Onyeaka   +3 more
wiley   +1 more source

Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis. [PDF]

Front Microbiol, 2022
Ren X, Hao Y, Wu B, Jia X, Niu M, Wang K, Li Z.   +6 more
europepmc   +1 more source

Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aim Cervical cancer is a major public health issue in Botswana, driven by high HIV prevalence and limited screening access. Molecular detection of high‐risk human papillomavirus (hrHPV) is crucial for prevention and early diagnosis.
Leabaneng Tawe
wiley   +1 more source

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. [PDF]

Hum Vaccin Immunother, 2022
Garland SM, Anagani M, Bhatla N, Chatterjee S, Lalwani S, Ross C, Group T, Lin J, Luxembourg A, Walia A, Tu Y.   +10 more
europepmc   +1 more source

Vaccination against human papillomavirus.

Einstein (Sao Paulo, Brazil), 2013
Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.
openaire   +2 more sources

Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening

International Journal of Cancer, Volume 158, Issue 5, Page 1348-1360, 1 March 2026.
What's New? While vaccination against high‐risk HPV infection, the primary cause of cervical malignancy, has demonstrated long‐term effectiveness in clinical trials, real‐life longitudinal data are lacking. Here, the authors present linked long‐term screening data on the effectiveness of bivalent HPV vaccination with a minimum follow‐up of 54 months ...
Timothy J. Palmer, Kimberley Kavanagh, Kate Cuschieri, Ross L. Cameron, Catriona Graham, Allan Wilson, Kirsty Roy   +6 more
wiley   +1 more source

Knowledge, attitude, and perception of the parents toward HPV vaccine administration to their children in Saudi Arabia: a cross-sectional study

Frontiers in Public Health
BackgroundHuman papillomavirus (HPV) infection is a major culprit of infection-related cancer globally. In Saudi Arabia, HPV vaccine was recently introduced.
Abubaker S. Bakhashab, Saja A. Aljilani, Noura M. Alkinaidri, Abdulaziz A. Felimban, Moheealdeen H. Habbal, Nawaf A. Bashah, Ragia H. Ghoneim, Diena Almasri, Razan K. Thabit, Masaad Saeed Almutairi, Abrar K. Thabit   +10 more
doaj   +1 more source

Intralesional bivalent and quadrivalent human papillomavirus vaccines didn't significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial. [PDF]

Arch Dermatol Res, 2023
Fawzy M, Nofal E, Abdelkhalek N, Ehab R.
europepmc   +1 more source